Evidence map›Paper›PMID 40946520›Full record

ArticleComputer methods and programs in biomedicine2025

Integration of nested cross-validation, automated hyperparameter optimization, high-performance computing to reduce and quantify the variance of test performance estimation of deep learning models.

Paul Calle, Averi Bates, Justin C Reynolds, Yunlong Liu, Haoyang Cui, Sinaro Ly, Chen Wang, Qinghao Zhang, Alberto J de Armendi, Shashank S Shettar and 3 more

Abstract read
In one paragraph

Article in Computer methods and programs in biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Octascope: A Lightweight Pre-Trained Model for Optical Coherence Tomography.IEEE access : practical innovations, open solutions · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Paul CalleSchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA.
Averi BatesSchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA.
Justin C ReynoldsSchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA.
Yunlong LiuSchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA.
Haoyang CuiSchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA.
Sinaro LySchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA.
Chen WangStephenson School of Biomedical Engineer, University of Oklahoma, Norman, 73019, OK, USA.
Qinghao ZhangStephenson School of Biomedical Engineer, University of Oklahoma, Norman, 73019, OK, USA.
Alberto J de ArmendiDepartment of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, OK, USA.
Shashank S ShettarDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, OK, USA.
Kar-Ming FuDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, OK, USA; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, OK, USA.
Qinggong TangStephenson School of Biomedical Engineer, University of Oklahoma, Norman, 73019, OK, USA; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, OK, USA. Electronic address: qtang@ou.edu.
Chongle PanSchool of Computer Science, University of Oklahoma, Norman, 73019, OK, USA; Stephenson School of Biomedical Engineer, University of Oklahoma, Norman, 73019, OK, USA. Electronic address: cpan@ou.edu.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2012 to 2022
$21.3M
Use of 3D Quantitative Optical Methods to Optimize Mebendazole Treatment of Ovarian CancerP20GM135009 · NIGMS · UNIVERSITY OF OKLAHOMA · PI Javier Antonio Jo · 2022 to 2026
$13.6M
Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney ViabilityR01DK133717 · NIDDK · UNIVERSITY OF MASSACHUSETTS AMHERST · PI POTTER, STEVEN, TANG, QINGGONG · 2022 to 2025
$2.5M
NCI NIH HHS P30 CA225520NIDDK NIH HHS R01 DK133717NIGMS NIH HHS P20 GM103639NIGMS NIH HHS P20 GM135009
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe variability and biases in the real-world performance benchmarking of deep learning models for medical imaging compromise their trustworthiness for real-world deployment. The common approach of holding out a single fixed test set fails to quantify the variance in the estimation of test performance metrics. This study introduces NACHOS (Nested and Automated Cross-validation and Hyperparameter Optimization using Supercomputing) to reduce and quantify the variance of test performance metrics of deep learning models.

methodsNACHOS integrates Nested Cross-Validation (NCV) and Automated Hyperparameter Optimization (AHPO) within a parallelized high-performance computing (HPC) framework. NACHOS was demonstrated on a chest X-ray repository and an Optical Coherence Tomography (OCT) dataset under multiple data partitioning schemes. Beyond performance estimation, DACHOS (Deployment with Automated Cross-validation and Hyperparameter Optimization using Supercomputing) is introduced to leverage AHPO and cross-validation to build the final model on the full dataset, improving expected deployment performance.

resultsThe findings underscore the importance of NCV in quantifying and reducing estimation variance, AHPO in optimizing hyperparameters consistently across test folds, and HPC in ensuring computational feasibility.

conclusionsBy integrating these methodologies, NACHOS and DACHOS provide a scalable, reproducible, and trustworthy framework for DL model evaluation and deployment in medical imaging. To maximize public availability, the full open-source codebase is provided at https://github.com/thepanlab/NACHOS.

Indexed as

Deep LearningAlgorithmsHumansReproducibility of ResultsTomography, Optical CoherenceDeep learningMedical imagingNested cross-validationPerformance evaluation

Identifiers

PMID40946520
PMCPMC12674930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.